Document is current

Any future updates will be listed below

Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo‐controlled study

Crossref DOI link: https://doi.org/10.1007/s10545-014-9715-6

Published Online: 2014-05-09

Published Print: 2014-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark